Skip to main content
NCBI home page
The Journal of Cell Biology logoLink to The Journal of Cell Biology
. 1981 Sep 1;90(3):670–674. doi: 10.1083/jcb.90.3.670

Effect of cell density on thrombin binding to a specific site on bovine vascular endothelial cells

PMCID: PMC2111896  PMID: 7287820

Abstract

We studied thrombin binding to proliferating and confluent endothelial cells derived from bovine vascular endothelium. [125]thrombin was incubated with nonconfluent or confluent endothelial cells and both the total amount bound and the amount linked in a 77,000-dalton thrombin- cell complex were determined. Approximately 230,000 molecules of thrombin bound per cell in nonconfluent cultures compared to 12,800 molecules per cell in confluent cultures. Approximately 67,7000 thrombin molecules were bound in an apparently covalent complex, Mr = 77,000, with each cell in sparse cultures, whereas only 4,600 thrombin molecules per cell were bound in this complex with confluent cultures. Similar studies with [125I]thrombin and endothelial cells derived from bovine cornea revealed no difference either in the total amount of thrombin bound or in the amount bound in the 77,000-dalton complex using sparse or confluent cultures. When confluent vascular endothelial cultures were wounded, additional cellular binding sites for the 77,000- dalton complex with thrombin appeared within 24 h. A 237% increase in the amount of thrombin bound to these sites was induced by a wound which resulted in a 20% decrease in cell number in the monolayer. There was no significant increase in thrombin binding to other cellular sites at 24 h. These experiments provide evidence that the first change in thrombin binding after injury is an increase in the cellular sites involved in the 77,000-dalton complex, and suggest that thrombin binding to endothelial cells may be important in the vascular response to injury.

Full Text

The Full Text of this article is available as a PDF (540.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baker J. B., Low D. A., Simmer R. L., Cunningham D. D. Protease-nexin: a cellular component that links thrombin and plasminogen activator and mediates their binding to cells. Cell. 1980 Aug;21(1):37–45. doi: 10.1016/0092-8674(80)90112-9. [DOI] [PubMed] [Google Scholar]
  2. Baker J. B., Simmer R. L., Glenn K. C., Cunningham D. D. Thrombin and epidermal growth factor become linked to cell surface receptors during mitogenic stimulation. Nature. 1979 Apr 19;278(5706):743–745. doi: 10.1038/278743a0. [DOI] [PubMed] [Google Scholar]
  3. Czervionke R. L., Smith J. B., Hoak J. C., Fry G. L., Haycraft D. L. Use of a radioimmunoassay to study thrombin-induced release of PGI2 from cultured endothelium. Thromb Res. 1979;14(4-5):781–786. doi: 10.1016/0049-3848(79)90132-4. [DOI] [PubMed] [Google Scholar]
  4. Davey M. G., Lüscher E. F. Actions of thrombin and other coagulant and proteolytic enzymes on blood platelets. Nature. 1967 Dec 2;216(5118):857–858. doi: 10.1038/216857a0. [DOI] [PubMed] [Google Scholar]
  5. Detwiler T. C., Feinman R. D. Kinetics of the thrombin-induced release of calcium (II) by platelets. Biochemistry. 1973 Jan 16;12(2):282–289. doi: 10.1021/bi00726a017. [DOI] [PubMed] [Google Scholar]
  6. Edy J., Collen D. The interaction in human plasma of antiplasmin, the fast-reacting plasmin inhibitor, with plasmin, thrombin, trypsin and chymotrypsin. Biochim Biophys Acta. 1977 Oct 13;484(2):423–432. doi: 10.1016/0005-2744(77)90098-5. [DOI] [PubMed] [Google Scholar]
  7. Fehrenbacher L., Gospodarowicz D., Shuman M. A. Synthesis of plasminogen activator by bovine corneal endothelial cells. Exp Eye Res. 1979 Sep;29(3):219–228. doi: 10.1016/0014-4835(79)90002-2. [DOI] [PubMed] [Google Scholar]
  8. Fenton J. W., 2nd, Fasco M. J., Stackrow A. B. Human thrombins. Production, evaluation, and properties of alpha-thrombin. J Biol Chem. 1977 Jun 10;252(11):3587–3598. [PubMed] [Google Scholar]
  9. Glenn K. C., Cunningham D. D. Thrombin-stimulated cell division involves proteolysis of its cell surface receptor. Nature. 1979 Apr 19;278(5706):711–714. doi: 10.1038/278711a0. [DOI] [PubMed] [Google Scholar]
  10. Gospodarowicz D., Bialecki H., Greenburg G. Purification of the fibroblast growth factor activity from bovine brain. J Biol Chem. 1978 May 25;253(10):3736–3743. [PubMed] [Google Scholar]
  11. Gospodarowicz D., Brown K. D., Birdwell C. R., Zetter B. R. Control of proliferation of human vascular endothelial cells. Characterization of the response of human umbilical vein endothelial cells to fibroblast growth factor, epidermal growth factor, and thrombin. J Cell Biol. 1978 Jun;77(3):774–788. doi: 10.1083/jcb.77.3.774. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gospodarowicz D., Mescher A. L., Birdwell C. R. Stimulation of corneal endothelial cell proliferations in vitro by fibroblast and epidermal growth factors. Exp Eye Res. 1977 Jul;25(1):75–89. doi: 10.1016/0014-4835(77)90248-2. [DOI] [PubMed] [Google Scholar]
  13. Gospodarowicz D., Moran J., Braun D., Birdwell C. Clonal growth of bovine vascular endothelial cells: fibroblast growth factor as a survival agent. Proc Natl Acad Sci U S A. 1976 Nov;73(11):4120–4124. doi: 10.1073/pnas.73.11.4120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Isaacs J. D., Savion N., Gospodarowicz D., Fenton J. W., 2nd, Shuman M. A. Covalent binding of thrombin to specific sites on corneal endothelial cells. Biochemistry. 1981 Jan 20;20(2):398–403. doi: 10.1021/bi00505a027. [DOI] [PubMed] [Google Scholar]
  15. Kirschner R. J., Federiuk C. S., Ford J. P., Shafer J. A. Detection and partial characterization of a protein in mouse fibroblasts that binds and inhibits trypsin. J Biol Chem. 1980 Jun 10;255(11):5468–5474. [PubMed] [Google Scholar]
  16. Lollar P., Hoak J. C., Owen W. G. Binding of thrombin to cultured human endothelial cells. Nonequilibrium aspects. J Biol Chem. 1980 Nov 10;255(21):10279–10283. [PubMed] [Google Scholar]
  17. Loskutoff D. J. Effect of thrombin on the fibrinolytic activity of cultured bovine endothelial cells. J Clin Invest. 1979 Jul;64(1):329–332. doi: 10.1172/JCI109457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Saito H., Goldsmith G. H., Moroi M., Aoki N. Inhibitory spectrum of alpha 2-plasmin inhibitor. Proc Natl Acad Sci U S A. 1979 Apr;76(4):2013–2017. doi: 10.1073/pnas.76.4.2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Savion N., Isaacs J. D., Gospodarowicz D., Shuman M. A. Internalization and degradation of thrombin and up regulation of thrombin-binding sites in corneal endothelial cells. J Biol Chem. 1981 May 10;256(9):4514–4519. [PubMed] [Google Scholar]
  20. Shuman M. A., Isaacs J. D., Maerowitz T., Savion N., Gospodarowicz D., Glenn K., Cunningham D., Fenton J. W., 2nd Endothelial cell and platelet binding sites for thrombin. Ann N Y Acad Sci. 1981;370:57–66. doi: 10.1111/j.1749-6632.1981.tb29721.x. [DOI] [PubMed] [Google Scholar]
  21. Spaet T. H., Erichson R. B. The vascular wall in the pathogenesis of thrombosis. Thromb Diath Haemorrh Suppl. 1966;21:67–86. [PubMed] [Google Scholar]
  22. Tollefsen D. M., Feagler J. R., Majerus P. W. The binding of thrombin to the surface of human platelets. J Biol Chem. 1974 Apr 25;249(8):2646–2651. [PubMed] [Google Scholar]
  23. Tollefsen D. M., Jackson C. M., Majerus P. W. Binding of the products of prothrombin activation to human platelets. J Clin Invest. 1975 Jul;56(1):241–245. doi: 10.1172/JCI108075. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Weksler B. B., Ley C. W., Jaffe E. A. Stimulation of endothelial cell prostacyclin production by thrombin, trypsin, and the ionophore A 23187. J Clin Invest. 1978 Nov;62(5):923–930. doi: 10.1172/JCI109220. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Cell Biology are provided here courtesy of The Rockefeller University Press

RESOURCES